Healthcare provider profile · identity verified

Frederick H Ovrom, MD

Internal Medicine · CORALVILLE, IA · NPI 1619941226

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1093	299
Amlodipine Besylate	Amlodipine Besylate	683	190
Losartan Potassium	Losartan Potassium	628	176
Lisinopril	Lisinopril	424	109
Hydrochlorothiazide	Hydrochlorothiazide	412	106
Levothyroxine Sodium	Levothyroxine Sodium	401	104
Metformin Hcl	Metformin Hcl	382	102
Omeprazole	Omeprazole	317	86
Rosuvastatin Calcium	Rosuvastatin Calcium	235	72
Metoprolol Succinate	Metoprolol Succinate	230	61
Eliquis	Apixaban	222	43
Simvastatin	Simvastatin	196	48
Gabapentin	Gabapentin	195	51
Tamsulosin Hcl	Tamsulosin Hcl	187	47
Pantoprazole Sodium	Pantoprazole Sodium	168	45
Allopurinol	Allopurinol	161	42
Furosemide	Furosemide	158	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	138	39
Alendronate Sodium	Alendronate Sodium	134	45
Metoprolol Tartrate	Metoprolol Tartrate	131	38
Pravastatin Sodium	Pravastatin Sodium	118	32
Glipizide	Glipizide	112	28
Carvedilol	Carvedilol	110	29
Ozempic	Semaglutide	105	16
Duloxetine Hcl	Duloxetine Hcl	101	24
Potassium Chloride	Potassium Chloride	100	31
Alprazolam	Alprazolam	96	23
Sertraline Hcl	Sertraline Hcl	89	19
Lovastatin	Lovastatin	86	21
Clopidogrel	Clopidogrel Bisulfate	85	24
Finasteride	Finasteride	85	24
Spironolactone	Spironolactone	74	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	72	19
Fluoxetine Hcl	Fluoxetine Hcl	71	18
Ezetimibe	Ezetimibe	70	16
Meloxicam	Meloxicam	70	20
Metformin Hcl Er	Metformin Hcl	66	17
Warfarin Sodium	Warfarin Sodium	66	20
Lorazepam	Lorazepam	64	21
Pioglitazone Hcl	Pioglitazone Hcl	64	14
Atenolol	Atenolol	63	18
Famotidine	Famotidine	62	18
Escitalopram Oxalate	Escitalopram Oxalate	61	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	60	suppressed
Xarelto	Rivaroxaban	60	14
Trazodone Hcl	Trazodone Hcl	59	19
Albuterol Sulfate Hfa	Albuterol Sulfate	58	25
Tramadol Hcl	Tramadol Hcl	55	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	54	suppressed
Fluticasone Propionate	Fluticasone Propionate	53	15
Jardiance	Empagliflozin	53	14
Labetalol Hcl	Labetalol Hcl	52	14
Citalopram Hbr	Citalopram Hydrobromide	50	13
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Bupropion Xl	Bupropion Hcl	42	13
Triamcinolone Acetonide	Triamcinolone Acetonide	42	21
Chlorthalidone	Chlorthalidone	41	14
Prednisone	Prednisone	41	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	11
Glimepiride	Glimepiride	38	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Glipizide Er	Glipizide	32	12
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Celecoxib	Celecoxib	31	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Acyclovir	Acyclovir	29	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Torsemide	Torsemide	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Topiramate	Topiramate	24	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Carbamazepine	Carbamazepine	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Methimazole	Methimazole	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Cephalexin	Cephalexin	18	16
Fludrocortisone Acetate	Fludrocortisone Acetate	18	suppressed
Unifine Pentips	Pen Needle, Diabetic	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Digoxin	Digoxin	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Amoxicillin	Amoxicillin	16	13
Benazepril Hcl	Benazepril Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Eszopiclone	Eszopiclone	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Ramipril	Ramipril	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Novolog Penfill	Insulin Aspart	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error